Prognostic prediction method, system and equipment

Abstract

The invention relates to a prognosis prediction method, system and equipment, which are applied to prognosis prediction of tumor cell reduction and deactivation and peritoneal hyperthermia perfusion chemotherapy. The invention belongs to the technical field of risk prediction. The method comprises the steps of obtaining prediction parameters of a target individual, and scoring the prediction parameters, thereby obtaining a total score of a prognosis prediction risk value of the target individual; obtaining the one-year survival possibility, the two-year survival possibility or the three-year survival possibility of the target individual through the total score and the preset survival possibility model, so that the prognosis condition of the target individual is judged through the survivalpossibility, and the higher the survival possibility is, the better the prognosis of the target individual is, and the higher the possibility of the long lifetime of the target individual is. A patient or a medical worker can accurately know the prognosis risk of gastric cancer peritoneal cancer treatment through tumor cell reduction and deactivation and abdominal cavity hyperthermia perfusion chemotherapy, and therefore a choice is made.

Description

technical field [0001] The invention belongs to the technical field of risk prediction, and in particular relates to a prognosis prediction method, system and equipment. Background technique [0002] Gastric cancer is one of the most common malignant tumors in the world, with a high mortality rate and a serious threat to human health. China is a country with a high incidence of gastric cancer. The number of cases and deaths accounted for 42.6% and 45.0% of the global gastric cancer incidence and death respectively, ranking fifth in incidence and sixth in mortality among 183 countries in the world. [0003] Peritoneal metastasis is the primary reason affecting the long-term survival of patients with gastric cancer, and it is the biggest challenge for the clinical diagnosis and treatment of advanced gastric cancer. Primary or secondary malignant tumors on the surface of the peritoneum are collectively referred to as peritoneal cancer, and peritoneal metastases from gastric ca...

AI Technical Summary

Problems solved by technology

At present, the independent prognostic factors affecting CRS+HIPEC treatment of GCPC are still inconclusive. The prediction of survival prognosis of GCPC patients after receiving CRS+HIPEC is limited to single-factor independent evaluation of single-center experience, and a complete prognosis prediction model has not yet been established.

Images